King C P Li

Author PubWeight™ 35.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 2007 2.17
2 Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology 2008 1.82
3 Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad Radiol 2006 1.60
4 Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Radiology 2006 1.51
5 Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. Radiology 2005 1.46
6 A primer on molecular biology for imagers: I. DNA, how does it work? Acad Radiol 2003 1.39
7 Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. Radiology 2005 1.39
8 Potential role of pulsed-high intensity focused ultrasound in gene therapy. Future Oncol 2006 1.29
9 Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study. Thromb Res 2007 1.21
10 Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice. J Nucl Med 2008 1.20
11 Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor. Bioorg Med Chem 2005 1.11
12 Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI. Mol Imaging 2002 1.00
13 A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis. Nanomedicine 2005 0.93
14 Vascular-targeted nanoparticles for molecular imaging and therapy. Methods Enzymol 2004 0.89
15 Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imaging. Bioconjug Chem 2010 0.89
16 Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model. Mol Cancer 2006 0.87
17 Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle. Int J Nanomedicine 2007 0.87
18 Augmentation of targeted delivery with pulsed high intensity focused ultrasound. Int J Hyperthermia 2008 0.87
19 Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature. Bioconjug Chem 2007 0.86
20 Acoustic fingerprints of dye-labeled protein submicrosphere photoacoustic contrast agents. J Biomed Opt 2009 0.84
21 Molecular theranostics: a primer for the imaging professional. AJR Am J Roentgenol 2011 0.83
22 Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice. Nucl Med Biol 2007 0.83
23 A system mathematical model of a cell-cell communication network in amyotrophic lateral sclerosis. Mol Biosyst 2013 0.83
24 Detection and localization of proteinuria by dynamic contrast-enhanced magnetic resonance imaging using MS325. J Am Soc Nephrol 2005 0.81
25 Molecular imaging and therapy directed at the neovasculature in pathologies. How imaging can be incorporated into vascular-targeted delivery systems to generate active therapeutic agents. IEEE Eng Med Biol Mag 2004 0.81
26 Molecular imaging of hepatocellular carcinoma. Gastroenterology 2004 0.80
27 Biomedical imaging in the postgenomic era: opportunities and challenges. Acad Radiol 2002 0.79
28 Multivalency of non-peptide integrin αVβ3 antagonist slows tumor growth. Mol Pharm 2013 0.78
29 Functional genomics guided with MR imaging: mouse tumor model study. Radiology 2003 0.78
30 Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-Ligands. Curr Radiopharm 2010 0.78
31 A primer on molecular biology for imagers: VII. Molecular imaging probes. Acad Radiol 2004 0.78
32 Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging? AJR Am J Roentgenol 2002 0.77
33 A primer on molecular biology for imagers: VIII. Equipment for imaging molecular processes. Acad Radiol 2004 0.76
34 Biomedical Imaging Research Opportunities Workshop II: report and recommendations. Radiology 2005 0.76
35 A primer on molecular biology for imagers: II. Transcription and gene expression. Acad Radiol 2004 0.75
36 A primer on molecular biology for imagers: IV. concepts and basic methods in molecular biology. Acad Radiol 2004 0.75
37 A primer on molecular biology for imagers: V. Genomics: a global approach to the study of genes. Acad Radiol 2004 0.75
38 Systems diagnostics: the systems approach to molecular imaging. AJR Am J Roentgenol 2009 0.75
39 A primer on molecular biology for imagers: III. Proteins: structure and function. Acad Radiol 2004 0.75
40 A primer on molecular biology for imagers: VI. Proteomics: the large-scale study of proteins. Acad Radiol 2004 0.75